SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001047469-10-000214
Filing Date
2010-01-19
Accepted
2010-01-19 16:19:24
Documents
13
Effectiveness Date
2010-01-19

Document Format Files

Seq Description Document Type Size
1 S-3ASR a2196110zs-3asr.htm S-3ASR 288298
2 EX-4.7 a2196110zex-4_7.htm EX-4.7 532999
3 EX-4.8 a2196110zex-4_8.htm EX-4.8 563841
4 EX-4.11 a2196110zex-4_11.htm EX-4.11 183934
5 EX-4.12 a2196110zex-4_12.htm EX-4.12 176014
6 EX-4.13 a2196110zex-4_13.htm EX-4.13 141983
7 EX-5.1 a2196110zex-5_1.htm EX-5.1 35125
8 EX-12.1 a2196110zex-12_1.htm EX-12.1 32190
9 EX-23.1 a2196110zex-23_1.htm EX-23.1 2883
10 G73437.JPG g73437.jpg GRAPHIC 8608
11 G619183.JPG g619183.jpg GRAPHIC 21021
12 G19562LA01I001.JPG g19562la01i001.jpg GRAPHIC 2798
13 G19562LA01I002.JPG g19562la01i002.jpg GRAPHIC 2801
  Complete submission text file 0001047469-10-000214.txt   2007909
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02140
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-164400 | Film No.: 10533500
SIC: 2835 In Vitro & In Vivo Diagnostic Substances